Use of potent, selective and non toxic c-kit inhibitors for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/404 (2006.01) A61K 31/00 (2006.01) A61K 31/015 (2006.01) A61K 31/095 (2006.01) A61K 31/40 (2006.01) A61K 31/403 (2006.01) A61K 31/415 (2006.01) A61K 31/4709 (2006.01) A61K 31/498 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61K 31/66 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2452366

The present invention relates to a method for inhibiting tumor angiogenesis comprising administering a c-kit inhibitor to a human in need of such treatment, more particularly a non toxic, potent and selective c-kit inhibitor, wherein said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.

La présente invention concerne une méthode d'inhibition de l'angiogénèse tumorale consistant à administrer un inhibiteur de matériel c chez un humain nécessitant un tel traitement, notamment un inhibiteur de matériel c, sélectif, puissant et non toxique, ledit inhibiteur étant incapable de favoriser la mort de cellules dépendantes de l'IL-3 cultivées en présence d'IL-3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of potent, selective and non toxic c-kit inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of potent, selective and non toxic c-kit inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of potent, selective and non toxic c-kit inhibitors for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1730839

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.